SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-072016
Filing Date
2010-08-04
Accepted
2010-08-03 21:35:53
Documents
11
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c98288e10vq.htm 10-Q 678587
2 EXHIBIT 31.1 c98288exv31w1.htm EX-31.1 5937
3 EXHIBIT 31.2 c98288exv31w2.htm EX-31.2 5965
4 EXHIBIT 32.1 c98288exv32w1.htm EX-32.1 2317
5 EXHIBIT 32.2 c98288exv32w2.htm EX-32.2 2404
  Complete submission text file 0000950123-10-072016.txt   7946167

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT celg-20100630.xml EX-101.INS 914169
7 EX-101 SCHEMA DOCUMENT celg-20100630.xsd EX-101.SCH 65863
8 EX-101 CALCULATION LINKBASE DOCUMENT celg-20100630_cal.xml EX-101.CAL 76414
9 EX-101 LABELS LINKBASE DOCUMENT celg-20100630_lab.xml EX-101.LAB 508316
10 EX-101 PRESENTATION LINKBASE DOCUMENT celg-20100630_pre.xml EX-101.PRE 303619
11 EX-101 DEFINITION LINKBASE DOCUMENT celg-20100630_def.xml EX-101.DEF 155554
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16132 | Film No.: 10989343
SIC: 2834 Pharmaceutical Preparations